Medical/Pharmaceuticals
tHIS ASEAN 2025 to Debut in Kuala Lumpur, Uniting Southeast Asia's Healthcare Powerhouses
KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- The Health Industry Series - ASEAN (tHIS ASEAN 2025), a groundbreaking event aimed at integrating healthcare resources across Southeast Asia, is set to take place in Kuala Lumpur during June 9-11. Co-located with the APHM International Healthca...
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology
* Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth SMITHFIELD, R.I., May 29, 2025 /PRNewswire/ -- Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge soluti...
AI Meets Audit Powerhouse: Qualifyze Launches Quality Insights Platform to Help Global Pharma Manage Supplier Site Risk
FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry, announces the launch ofQuality Insights Platform, an AI-powered platform that transforms the world's largest pharmaceutical audit database into a st...
China's HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC
SHANGHAI, May 29, 2025 /PRNewswire/ -- The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan,China's first domestically developed antibody-drug conjugate (ADC), for treatment of adult patients with unresectable locally advanced or metastatic non-smal...
The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer
Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about and understanding brain cancers, and the potential strategies to treat them. COPENHAGEN, Denmark, May 29, 2025 /PRNewswire/ -- HM King Frederik of Denmark presented neur...
CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens
Record international participation reflects renewed momentum in pharma
manufacturing and global sourcing, as easing tariffs fuel growth
SHANGHAI, May 29, 2025 /PRNewswire/ -- CPHI & PMEC China
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA
SHENZHEN, China, May 28, 2025 /PRNewswire/ -- On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its independently developed innovative product, GB18. Moreover, GB18 has previo...
Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies
SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography
MELBOURNE, Australia, May 29, 2025 /PRNewswire/ -- IonOpticks
Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders
Metabolomic profiling uncovered how maternal diet and metabolism may contribute to the risk of ADHD and autism in children MORRISVILLE, N.C., May 28, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, di...
Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities
Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certifi...
Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life – Gedeon Richter at the World Congress on Endometriosis
SYDNEY, May 28, 2025 /PRNewswire/ --Gedeon Richter
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography
MELBOURNE, Australia, May 28, 2025 /PRNewswire/ -- IonOpticks
Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain
TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for exclusive rights to the commercialization of clobeta...
NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities
- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification for air and ocean frei...
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ofVibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr. Jawa succeeds EpiVax founder and Executive Chairw...
Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
* EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. * The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs ...
2025 World Brain Day Dedicated to Brain Health for All Ages
LONDON, May 28, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health for All Ages as the theme for the 2025 World Brain Day (WBD 2025), taking place on Tuesday, July 22. This global campaign aims to raise awareness of the importance of supporting brain ...
Perennial Holdings Signs Agreement with Guangzhou Metro to Establish the First Wholly Foreign-Owned Tertiary General Hospital in Guangzhou and Southern China
SINGAPORE, May 28, 2025 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") entered into an agreement with Guangzhou Metro Group Co. Ltd ("Guangzhou Metro"), where Perennial Holdings will lease approximately 105,000 square metres of space and invest approximatelyRMB1 billion...
CARsgen's Satri-cel Granted Priority Review by the NMPA
SHANGHAI, May 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has granted Priority R...
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 315 media titles]
2026-02-10 14:00Mastercard Launches Portfolio of Fleet Solutions in Asia Pacific
[Picked up by 311 media titles]
2026-02-04 09:00Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 300 media titles]
2026-02-10 13:31Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
[Picked up by 296 media titles]
2026-02-09 10:00InfoComm China Unveils State of China's Pro AV Market and Opportunities 2026 Industry White-Paper Report
[Picked up by 294 media titles]
2026-02-10 08:00